FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
第一作者:
Tingting,Song
第一单位:
Department of Cardiology, The Second Hospital of Hebei Medical University, 215 West Heping Road, Shijiazhuang, 050000, China.
作者:
医学主题词
老年人(Aged);冠状动脉再狭窄(Coronary Restenosis);冠状动脉狭窄(Coronary Stenosis);药物洗脱支架(Drug-Eluting Stents);能量代谢(Energy Metabolism);女(雌)性(Female);成纤维细胞生长因子(Fibroblast Growth Factors);人类(Humans);炎症介导素类(Inflammation Mediators);肾(Kidney);男(雄)性(Male);中年人(Middle Aged);试验预期值(Predictive Value of Tests);前瞻性研究(Prospective Studies);危险性评估(Risk Assessment);危险因素(Risk Factors);疾病严重程度指数(Severity of Illness Index);时间因素(Time Factors);治疗结果(Treatment Outcome);心室功能, 左(Ventricular Function, Left)
DOI
10.1186/s12872-020-01839-w
PMID
33413149
发布时间
2021-12-04
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



